Literature DB >> 776335

Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease.

R M Galbraith, N el Sheikh, B Portmann, A L Eddleston, R Williams, V Parsons, M Bewick, C S Ogg.   

Abstract

Evidence of chronic hepatitis was found on histological examination in nine out of 15 patients positive for hepatitis-B surface antigen (HBsAg) who had either chronic renal failure or a functioning renal transplant. Cirrhosis had already developed in three of the patients, who deteriorated rapidly and died. Liver biopsies from the remaining 12 patients showed the features of chronic aggressive hepatitis in two, chronic persistent hepatitis in four, and minor histological lesions in six. The persistence of HBsAg in patients with renal failure or in those receiving immunosuppressive drugs after a transplant must indicate some impairment of the normal immune response to hepatitis-B viral antigens. Nevertheless, cellular or humoral immunity to HBsAg was detected in all eight patients with chronic hepatitis tested compared with only one out of five with minimal liver lesions, which suggests that the severity of the liver damage may be directly related to the degree of immunocompetence.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776335      PMCID: PMC1640768          DOI: 10.1136/bmj.1.6024.1495

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  Irreversible liver damage after azathioprine.

Authors:  Z Zarday; F J Veith; M L Gliedman; R Soberman
Journal:  JAMA       Date:  1972-11-06       Impact factor: 56.272

2.  Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.

Authors:  W A Briggs; J M Lazarus; A G Birtch; C L Hampers; E B Hager; J P Merrill
Journal:  Arch Intern Med       Date:  1973-07

3.  Liver disease in kidney transplant patients receiving azathioprine.

Authors:  P Ireland; A Rashid; F von Lichtenberg; T Cavallo; J P Merrill
Journal:  Arch Intern Med       Date:  1973-07

4.  Immunological studies of Australia antigen carriers with and without liver diseases.

Authors:  J O Nielsen; V Reinicke; O Dietrichson; V Andersen; M Thomsen; E Andersen
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

5.  Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

Authors:  W D Reed; R B Stern; A L Eddleston; R Williams; A J Zuckerman; A Bowes; P M Earl
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

6.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

7.  Asymptomatic liver disease in hepatitis B antigen carriers.

Authors:  I L Woolf; B E Boyes; D M Jones; J S Whittaker; E Tapp; R N MacSween; P H Renton; F Stratton; I W Dymock
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

8.  A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen.

Authors:  L O Magnius; A Lindholm; P Lundin; S Iwarson
Journal:  JAMA       Date:  1975-01-27       Impact factor: 56.272

9.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

10.  Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.

Authors:  W M Newberry; J P Sanford
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

View more
  4 in total

1.  Letter: Hepatitis in patients with chronic renal failure.

Authors:  E N Wardle
Journal:  Br Med J       Date:  1976-07-10

Review 2.  Pathologic aspects of cirrhosis. A review.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

3.  Negative selection of patients for dialysis and transplantation in the United Kingdom.

Authors:  V Parsons; M Bewick; S A Snowden; A Eddleston; P M Lock; A H Uttley
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02

4.  Liver disease and the e antigen in HBsAg carriers with chronic renal failure.

Authors:  G P Coughlin; A G Van Deth; A P Disney; J Hay; A G Wangel
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.